Search
Descriptor English: Clopidogrel
Descriptor Spanish: Clopidogrel
Descriptor clopidogrel
Entry term(s) Clopidogrel Mepha
Clopidogrel Sandoz
Clopidogrel-Mepha
Iscover
PCR 4099
PCR-4099
Plavix
SC 25989C
SC 25990C
SR 25989
besilato de clopidogrel
bisulfato de clopidogrel
hidrocloruro de clopidogrel
isómero-(+)(S) del clopidogrel
napadisilato de clopidogrel
Scope note: Análogo de la ticlopidina y antagonista de los receptores purinérgicos plaquetarios P2Y que inhibe la AGREGACIÓN PLAQUETARIA mediada por el difosfato de adenosina. Se usa para prevenir la TROMBOEMBOLIA en pacientes con ARTERIOPATÍAS OCLUSIVAS, INFARTO DE MIOCARDIO, ACCIDENTE CEREBROVASCULAR o FIBRILACIÓN AURICULAR.
Descriptor Portuguese: Clopidogrel
Descriptor French: Clopidogrel
Entry term(s): Clopidogrel Besilate
Clopidogrel Besylate
Clopidogrel Bisulfate
Clopidogrel Hydrochloride
Clopidogrel Mepha
Clopidogrel Napadisilate
Clopidogrel Sandoz
Clopidogrel, (+)(S)-isomer
Clopidogrel-Mepha
Iscover
PCR 4099
PCR-4099
Plavix
SC 25989C
SC 25990C
SR 25989
Tree number(s): D02.886.778.823.500.500
D03.383.725.849.500.500
D03.383.903.830.500.500
D03.633.100.928.500.500
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000077144
Scope note: A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Registry Number: A74586SNO7
CAS Type 1 Name: Methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno(3,2-c)pyridin-5-yl)acetate
Public MeSH Note: 2019; CLOPIDOGREL was indexed under TICLOPIDINE 1988-2018
History Note: 2019 (1988)
DeCS ID: 57516
Unique ID: D000077144
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/07/09
Clopidogrel - Preferred
Concept UI M0155432
Scope note A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION.
Preferred term Clopidogrel
SC 25989C - Narrower
Concept UI M0155428
Preferred term SC 25989C
SC 25990C - Narrower
Concept UI M0155429
Preferred term SC 25990C
SR 25989 - Narrower
Concept UI M0155430
Preferred term SR 25989
Clopidogrel-Mepha - Narrower
Concept UI M000624947
Preferred term Clopidogrel-Mepha
Entry term(s) Clopidogrel Mepha
Clopidogrel Sandoz - Narrower
Concept UI M000624946
Preferred term Clopidogrel Sandoz
Iscover - Narrower
Concept UI M0446644
Preferred term Iscover
Clopidogrel Napadisilate - Narrower
Concept UI M0568441
Preferred term Clopidogrel Napadisilate
Clopidogrel Hydrochloride - Narrower
Concept UI M0584825
Preferred term Clopidogrel Hydrochloride
PCR 4099 - Narrower
Concept UI M0155425
Preferred term PCR 4099
Entry term(s) PCR-4099
Clopidogrel Besylate - Narrower
Concept UI M0584824
Preferred term Clopidogrel Besylate
Entry term(s) Clopidogrel Besilate
Clopidogrel, (+)(S)-isomer - Narrower
Concept UI M0323598
Preferred term Clopidogrel, (+)(S)-isomer
Plavix - Narrower
Concept UI M0155427
Preferred term Plavix
Clopidogrel Bisulfate - Narrower
Concept UI M0424331
Preferred term Clopidogrel Bisulfate



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey